Long-term results of Endonasal Endoscopic Transsphenoidal resection of nonfunctioning pituitary Macroadenomas

Neurosurgery

Volumn 76, Issue 1, 2015, Pages 42-52

  Dallapiazza, Robert F ^a   Grober, Yuval ^a   Starke, Robert M ^a   Laws, Edward R ^b   Jane, John A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Endoscopic; Follow up; Nonfunctioning pituitary macroadenoma; Pituitary tumor; Transsphenoidal

Indexed keywords

STEROID;

ADULT; AGED; ARTICLE; BRAIN RADIOGRAPHY; CANCER PATIENT; CANCER SURGERY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; ENDOCRINE DISEASE; ENDONASAL ENDOSCOPIC TRANSSPHENOIDAL RESECTION; ENDOSCOPIC SURGERY; FEMALE; FOLLOW UP; GAMMA KNIFE RADIOSURGERY; HEADACHE; HUMAN; HYPERCORTISOLISM; HYPOPHYSIS ADENOMA; KAPLAN MEIER METHOD; KNOSP SCORE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEUROIMAGING; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SCORING SYSTEM; STEROID THERAPY; SYMPTOM; TRANSSPHENOIDAL HYPOPHYSECTOMY; TREATMENT OUTCOME; TUMOR INVASION; TUMOR RECURRENCE; TUMOR VOLUME; UNIVARIATE ANALYSIS; VISUAL IMPAIRMENT; ADENOMA; DISEASE FREE SURVIVAL; MIDDLE AGED; MORTALITY; NATURAL ORIFICE TRANSLUMINAL ENDOSCOPIC SURGERY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PATHOLOGY; PITUITARY NEOPLASMS; TIME; VERY ELDERLY;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NATURAL ORIFICE ENDOSCOPIC SURGERY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PITUITARY NEOPLASMS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84926134637     PISSN: 0148396X     EISSN: 15244040     Source Type: Journal    
DOI: 10.1227/NEU.0000000000000563     Document Type: Article

References (40)

1. Charalampaki P, Reisch R, Ayad A, et al. Endoscopic endonasal pituitary surgery: surgical and outcome analysis of 50 cases. J Clin Neurosci. 2007;14(5):410-415.
2. Dehdashti AR, Ganna A, Karabatsou K, Gentili F. Pure endoscopic endonasal approach for pituitary adenomas: early surgical results in 200 patients and comparison with previous microsurgical series. Neurosurgery. 2008;62(5):1006-1015; discussion 1015-1017.
3. Gondim JA, Almeida JP, Albuquerque LA, et al. Endoscopic endonasal approach for pituitary adenoma: surgical complications in 301 patients. Pituitary. 2011;14 (2):174-183.
4. Jho HD, Carrau RL. Endoscopic endonasal transsphenoidal surgery: experience with 50 patients. J Neurosurg. 1997;87(1):44-51.
5. Nakao N, Itakura T. Surgical outcome of the endoscopic endonasal approach for non-functioning giant pituitary adenoma. J Clin Neurosci. 2011;18(1):71-75.
6. Uren B, Vrodos N, Wormald PJ. Fully endoscopic transsphenoidal resection of pituitary tumors: technique and results. Am J Rhinol. 2007;21(4):510-514.
7. Yano S, Kawano T, Kudo M, et al. Endoscopic endonasal transsphenoidal approach through the bilateral nostrils for pituitary adenomas. Neurol Med Chir (Tokyo). 2009;49(1):1-7.
8. Altman D. Practical Statistics For Medical Research. Boca Raton, FL: Chapman and Hall/CRC; 1999.
9. Knosp E, Stiener E, Kitz K, Matula C. Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery. 1993;33(4):610-617.
10. Gondim JA, Almeida JP, Albuquerque LA, Gomes EF, Schops M. Giant pituitary adenomas: surgical outcomes of 50 cases operated on by the endonasal endoscopic approach. World Neurosurg. 2014;82(1-2):e281-e290.
11. Hofstetter CP, Nanaszko MJ, Mubita LL, Tsiouris J, Anand VK, Schwartz TH. Volumetric classification of pituitary macroadenomas predicts outcome and morbidity following endoscopic endonasal transsphenoidal surgery. Pituitary. 2012;15(3):450-463.
12. Comtois R, Beauregard H, Somma M, Serri O, Aris-Jilwan N, Hardy J. The clinical and endocrine outcome to trans-sphenoidal microsurgery of nonsecreting pituitary adenomas. Cancer. 1991;68(4):860-866.
13. Ebersold MJ, Laws ER Jr, Scheithauer BW, Randall RV. Pituitary apoplexy treated by transsphenoidal surgery: a clinicopathological and immunocytochemical study. J Neurosurg. 1983;58(3):315-320.
14. Ferrante E, Ferraroni M, Castrignanò T, et al. Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors. Eur J Endocrinol. 2006;155(6):823-829.
15. Greenman Y, Ouaknine G, Veshchev I, Reider-Groswasser II, Segev Y, Stern N. Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth. Clin Endocrinol (Oxf). 2003;58(6): 763-769.
16. Losa M, Mortini P, Barzaghi R, et al. Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence. J Neurosurg. 2008;108(3):525-532.
17. O'Sullivan EP, Woods C, Glynn N, et al. The natural history of surgically treated but radiotherapy-naive nonfunctioning pituitary adenomas. Clin Endocrinol (Oxf). 2009;71(5):709-714.
18. Park P, Chandler WF, Barkan AL, et al. The role of radiation therapy after surgical resection of nonfunctional pituitary macroadenomas. Neurosurgery. 2004;55(1): 100-106; discussion 106-107.
19. Turner HE, Stratton IM, Byrne JV, Adams CB, Wass JA. Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation: a follow-up study. Clin Endocrinol (Oxf). 1999;51(3):281-284.
20. Woollons AC, Hunn MK, Rajapakse YR, et al. Non-functioning pituitary adenomas: indications for postoperative radiotherapy. Clin Endocrinol (Oxf). 2000; 53(6):713-717.
21. Zhang X, Fei Z, Zhang J, et al. Management of nonfunctioning pituitary adenomas with suprasellar extensions by transsphenoidal microsurgery. Surg Neurol. 1999;52(4):380-385.
22. Chang EF, Zada G, Kim S, et al. Long-term recurrence and mortality after surgery and adjuvant radiotherapy for nonfunctional pituitary adenomas. J Neurosurg. 2008;108(4):736-745.
23. Meij BP, Lopes MB, Ellegala DB, Alden TD, Laws ER Jr. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery. J Neurosurgery. 2002;96(2):195-208.
24. Greenman Y, Stern N. How should a nonfunctioning pituitary macroadenoma be monitored after debulking surgery? Clin Endocrinol (Oxf). 2009;70(6):829-832.
25. Picozzi P, Losa M, Mortini P, et al. Radiosurgery and the prevention of regrowth of incompletely removed nonfunctioning pituitary adenomas. J Neurosurg. 2005;102 (suppl):71-74.
26. Mingione V, Yen CP, Vance ML, et al. Gamma surgery in the treatment of nonsecretory pituitary macroadenoma. J Neurosurgery. 2006;104(6):876-883.
27. Sheehan JP, Kondziolka D, Flickinger J, Lunsford LD. Radiosurgery for residual or recurrent nonfunctioning pituitary adenoma. J Neurosurg. 2002;97(5 suppl):408-414.
28. Sheehan JP, Kondziolka D, Flickinger J, Lunsford LD. Radiosurgery for nonfunctioning pituitary adenoma. Neurosurg Focus. 2003;14(5):e9.
29. Sheehan JP, Starke RM, Mathieu D, et al. Gamma Knife radiosurgery for the management of nonfunctioning pituitary adenomas: a multicenter study. J Neurosurg. 2013;119(2):446-456.
30. Starke RM, Williams BJ, Jane JA Jr, Sheehan JP. Gamma Knife surgery for patients with nonfunctioning pituitary macroadenomas: predictors of tumor control, neurological deficits, and hypopituitarism. J Neurosurg. 2012;117(1): 129-135.
31. Frank G, Pasquini E, Farneti G, et al. The endoscopic versus the traditional approach in pituitary surgery. Neuroendocrinology. 2006;83(3-4):240-248.
32. Cappabianca P, Cavallo LM, Colao A, de Divitiis E. Surgical complications associated with the endoscopic endonasal transsphenoidal approach for pituitary adenomas. J Neurosurg. 2002;97(2):293-298.
33. Nomikos P, Ladar C, Fahlbusch R, Buchfelder M. Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas: a study on 721 patients. Acta Neurochir (Wien)). 2004;146(1):27-35.
34. Kelly DF, Oskouian RJ, Fineman I. Collagen sponge repair of small cerebrospinal fluid leaks obviates tissue grafts and cerebrospinal fluid diversion after pituitary surgery. Neurosurgery. 2001;49(4):885-889; discussion 889-890.
35. Shiley SG, Limonadi F, Delashaw JB, et al. Incidence, etiology, and management of cerebrospinal fluid leaks following trans-sphenoidal surgery. Laryngoscope. 2003; 113(8):1283-1288.
36. Crowley RW, Dumont AS, Jane JA Jr. Bilateral intracavernous carotid artery pseudoaneurysms as a result of sellar reconstruction during the transsphenoidal resection of a pituitary macroadenoma: case report. Minim Invasive Neurosurg. 2009;52(1):44-48.
37. Starke RM, Raper DM, Payne SC, Vance ML, Oldfield EH, Jane JA Jr. Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission. J Clin Endocrinol Metab. 2013;98(8):3190-3198.
38. Dallapiazza R, Bond AE, Grober Y, et al. Retrospective analysis of a concurrent series of microscopic versus endoscopic transsphenoidal surgeries for Knosp grades 0-2 nonfunctioning pituitary macroadenomas at a single institution. J Neurosurg. 2014;121(3):511-517.
39. Koc K, Anik I, Ozdamar D, Cabuk B, Keskin G, Ceylan S. The learning curve in endoscopic pituitary surgery and our experience. Neurosurg Rev. 2006;29(4): 298-305; discussion 305. Epub 2006 Aug 26.
40. Rudnik A, Zawadzki T, Galuszka-Ignasiak B, et al. Endoscopic transsphenoidal treatment in recurrent and residual pituitary adenomas-first experience. Minim Invasive Neurosurg. 2006;49(1):10-14.